GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 8/14/2026 3:48:44 PM | View | Financials | Earnings | WIRE | 2Q 2026 | Rev $207,898 +106.0% | Assets $4,282,694 | EPS -$0.90 | Export Earnings Model | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 8/14/2026 3:42:08 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $207,898 +106.0% | Assets $4,282,694 | EPS -$0.90 | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 7/2/2026 4:08:13 PM | View | Proxy | SEC | Y 2025 | ||||||
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 5/15/2026 8:43:41 AM | View | Financials | Earnings | WIRE | 1Q 2026 | Rev $162,092 -0.9% | Assets $6,763,346 | EPS -$1.28 | Export Earnings Model | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 5/15/2026 8:21:33 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $162,092 -0.9% | Assets $6,763,346 | EPS -$1.28 | |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 3/31/2026 7:03:38 AM | View | Financials | Earnings | WIRE | Y 2025 | Rev $303,385 +31.4% | Assets $5,366,211 | EPS -$7.08 | Export Earnings Model | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 3/30/2026 5:43:44 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $1,005,471 +65.5% | Assets $5,366,211 | EPS -$11.73 | |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 11/13/2025 1:53:03 PM | View | Financials | Earnings | WIRE | 3Q 2025 | Rev $437,602 +223.4% | Assets $6,689,344 | EPS -$0.66 | Export Earnings Model | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 11/13/2025 1:42:59 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $437,602 +223.4% | Assets $6,689,344 | EPS -$0.66 | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 9/2/2025 6:04:21 AM | View | Proxy | SEC | Y 2024 | ||||||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 8/27/2025 6:04:14 AM | View | Proxy | SEC | Y 2024 | ||||||
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 8/13/2025 4:15:30 PM | View | Financials | Earnings | WIRE | 2Q 2025 | Rev $100,932 -19.2% | Assets $4,181,938 | EPS -$1.25 | Export Earnings Model | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 8/13/2025 2:53:32 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $100,932 -19.2% | Assets $4,181,938 | EPS -$1.25 | |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 5/15/2025 4:33:04 PM | View | Financials | Earnings | WIRE | 1Q 2025 | Rev $163,552 +40.4% | Assets $5,977,867 | EPS -$1.56 | Export Earnings Model | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 5/15/2025 10:16:40 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $163,552 +40.4% | Assets $5,977,867 | EPS -$1.56 | |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 3/28/2025 7:01:09 AM | View | Financials | Earnings | WIRE | Y 2024 | Rev $230,846 +83.7% | Assets $5,759,345 | EPS -$14.20 | Export Earnings Model | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 3/27/2025 4:14:13 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $607,574 +139.6% | Assets $5,759,345 | EPS -$18.55 | |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 11/14/2024 2:33:13 PM | View | Financials | Earnings | WIRE | 3Q 2024 | Rev $135,293 +164.3% | Assets $7,420,893 | EPS -$0.93 | Export Earnings Model | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 11/14/2024 2:03:30 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $135,293 +164.3% | Assets $7,420,893 | EPS -$0.93 | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 10/15/2024 3:47:24 PM | View | Proxy | SEC | Y 2023 | ||||||
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 8/14/2024 11:02:08 AM | View | Financials | Earnings | WIRE | 2Q 2024 | Rev $124,972 +109.9% | Assets $4,327,251 | EPS -$4.23 | Export Earnings Model | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 8/14/2024 10:48:15 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $124,972 +109.9% | Assets $4,327,251 | EPS -$4.23 | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 5/30/2024 2:16:22 PM | View | Proxy | SEC | Y 2023 | ||||||
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 5/15/2024 1:46:19 PM | View | Financials | Earnings | WIRE | 1Q 2024 | Rev $116,463 +578.2% | Assets $8,379,108 | EPS $0.03 | Export Earnings Model | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 5/15/2024 12:06:28 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $116,463 +578.2% | Assets $8,379,108 | EPS $0.03 | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 4/1/2024 2:49:54 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $253,573 +13.6% | Assets $7,783,771 | EPS -$0.99 | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 11/20/2023 12:55:29 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $51,188 -69.6% | Assets $9,150,212 | EPS $9.13 | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | 8/25/2023 3:36:03 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $59,532 +31.8% | Assets $7,358,738 | EPS -$16.84 |